Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia

NCT04870866 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT04870866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04870866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
Lead sponsor
University Hospital, Akershus
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 5, 2019
Completion date
June 16, 2027
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia telangiectasia